The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Rational Design of α-Helical Antimicrobial Peptides with Enhanced Activities and Specificity/Therapeutic Index
Open accessAbstract
In the present study, the 26-residue peptide sequence Ac-KWKSFLKTFKSAVKTVLHTALKAISS-amide (V681) was utilized as the framework to study the effects of peptide hydrophobicity/hydrophilicity, amphipathicity, and helicity (induced by single amino acid substitutions in the center of the polar and nonpolar faces of the amphipathic helix) on biological activities. The peptide analogs were also studied by temperature profiling in reversed-phase high performance liquid chromatography, from 5 to 80 degrees C, to evaluate the self-associating ability of the molecules in solution, another important parameter in understanding peptide antimicrobial and hemolytic activities. A higher ability to self-associate in solution was correlated with weaker antimicrobial activity and stronger hemolytic activity of the peptides. Biological studies showed that strong hemolytic activity of the peptides generally correlated with high hydrophobicity, high amphipathicity, and high helicity. In most cases, the D-amino acid substituted peptides possessed an enhanced average antimicrobial activity compared with L-diastereomers. The therapeutic index of V681 was improved 90- and 23-fold against Gram-negative and Gram-positive bacteria, respectively. By simply replacing the central hydrophobic or hydrophilic amino acid residue on the nonpolar or the polar face of these amphipathic derivatives of V681 with a series of selected D-/L-amino acids, we demonstrated that this method has excellent potential for the rational design of antimicrobial peptides with enhanced activities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The crisis in antibiotic resistance
Neu, H. C. (1992) · Science · doi:10.1126/science.257.5073.1064 · Cited by 2,834
Zasloff, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.15.5449 · Cited by 2,305
Shai, Y. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00200-x · Cited by 1,869
Cationic peptides: a new source of antibiotics
Hancock, R. E. W., & Lehrer, R. (1998) · Trends in Biotechnology · doi:10.1016/s0167-7799(97)01156-6 · Cited by 1,336
Self-citationHancock, R. E. (1997) · The Lancet · doi:10.1016/s0140-6736(97)80051-7 · Cited by 1,096
Self-citationThe helical hydrophobic moment: a measure of the amphiphilicity of a helix
Eisenberg, D., Weiss, R. M., & Terwilliger, T. C. (1982) · Nature · doi:10.1038/299371a0 · Cited by 1,056
Matsuzaki, K. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00197-2 · Cited by 1,010
Daum, G. (1985) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(85)90002-4 · Cited by 858
Pouny, Y., Rapaport, D., Mor, A., Nicolas, P., & Shai, Y. (1992) · Biochemistry · doi:10.1021/bi00164a017 · Cited by 687
Animal antimicrobial peptides: An overview
Andreu, D., & Rivas, L. (1998) · Biopolymers · doi:10.1002/(sici)1097-0282(1998)47:6<415::aid-bip2>3.0.co;2-d · Cited by 618
Role of membranes in the activities of antimicrobial cationic peptides
Hancock, R. (2002) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(01)00480-3 · Cited by 574
Self-citationChristensen, B., Fink, J., Merrifield, R. B., & Mauzerall, D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5072 · Cited by 514
Oren, Z., & Shai, Y. (1997) · Biochemistry · doi:10.1021/bi962507l · Cited by 416
Interaction of Cationic Antimicrobial Peptides with Model Membranes
Zhang, L., Rozek, A., & Hancock, R. E. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104925200 · Cited by 410
Self-citationDathe, M., Wieprecht, T., Nikolenko, H., Handel, L., Maloy, W. L., MacDonald, D. L., Beyermann, M., & Bienert, M. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00055-0 · Cited by 409
Electrically gated ionic channels in lipid bilayers
Ehrenstein, G., & Lecar, H. (1977) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583500000123 · Cited by 393
Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity
Steinberg, D. A., Hurst, M. A., Fujii, C. A., Kung, A. H., Ho, J. F., Cheng, F. C., Loury, D. J., & Fiddes, J. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.8.1738 · Cited by 384
Monera, O. D., Sereda, T. J., Zhou, N. E., Kay, C. M., & Hodges, R. S. (1995) · Journal of Peptide Science · doi:10.1002/psc.310010507 · Cited by 365
Self-citationAntimicrobial Peptides: Properties and Applicability
Hof, W. V. T., Veerman, E. C. I., Helmerhorst, E. J., & Amerongen, A. V. N. (2001) · Biological Chemistry · doi:10.1515/bc.2001.072 · Cited by 354
Sitaram, N., & Nagaraj, R. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00199-6 · Cited by 353
Design of model amphipathic peptides having potent antimicrobial activities
Blondelle, S. E., & Houghten, R. A. (1992) · Biochemistry · doi:10.1021/bi00165a020 · Cited by 352
Ganz, T., & Lehrer, R. I. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90145-7 · Cited by 337
Mootz, H. D., & Marahiel, M. A. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.21.6843-6850.1997 · Cited by 300
Shortened cecropin A‐melittin hybrids Significant size reduction retains potent antibiotic activity
Andreu, D., Ubach, J., Boman, A., Wåhlin, B., Wade, D., Merrifield, R. B., & Boman, H. G. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80377-s · Cited by 267
Kondejewski, L. H., Jelokhani-Niaraki, M., Farmer, S. W., Lix, B., Kay, C. M., Sykes, B. D., Hancock, R. E. W., & Hodges, R. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13181 · Cited by 246
Self-citationDuclohier, H., Molle, G., & Spach, G. (1989) · Biophysical Journal · doi:10.1016/s0006-3495(89)82746-8 · Cited by 222
Reviving the antibiotic miracle?
Travis, J. (1994) · Science · doi:10.1126/science.8153615 · Cited by 202
Blondelle, S. E., Lohner, K., & Aguilar, M.-I. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00202-3 · Cited by 197
Cationic Peptides: Distribution and Mechanisms of Resistance
Devine, D., & Hancock, R. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612023395501 · Cited by 160
Self-citationDiastereomers of Cytolysins, a Novel Class of Potent Antibacterial Peptides
Shai, Y., & Oren, Z. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.13.7305 · Cited by 160
Influence of Proline Residues on the Antibacterial and Synergistic Activities of α-Helical Peptides
Zhang, L., Benz, R., & Hancock, R. E. W. (1999) · Biochemistry · doi:10.1021/bi9904104 · Cited by 145
Self-citationSalgado, J., Grage, S. L., Kondejewski, L. H., Hodges, R. S., McElhaney, R. N., & Ulrich, A. S. (2001) · Journal of Biomolecular NMR · doi:10.1023/a:1012946026231 · Cited by 123
Self-citationLee, D. L., & Hodges, R. S. (2003) · Biopolymers · doi:10.1002/bip.10374 · Cited by 120
Self-citationHost-defense Antimicrobial Peptides: Importance of Structure for Activity
Sitaram, N., & Nagaraj, R. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612023395358 · Cited by 105
Induced conformational states of amphipathic peptides in aqueous/lipid environments
Blondelle, S. E., Ostresh, J. M., Houghten, R. A., & Pérez‐Payá, E. (1995) · Biophysical Journal · doi:10.1016/s0006-3495(95)80194-3 · Cited by 105
Chen, Y., Mant, C. T., & Hodges, R. S. (2002) · Journal of Peptide Research · doi:10.1046/j.1397-002x.2001.10994.x · Cited by 94
Self-citationLee, D. L., Powers, J. P. S., Pflegerl, K., Vasil, M. L., Hancock, R. E. W., & Hodges, R. S. (2004) · Journal of Peptide Research · doi:10.1046/j.1399-3011.2003.00106.x · Cited by 87
Self-citationZhang, L., Falla, T. J., Wu, M., Fidai, S., Burian, J., Kay, W. W., & Hancock, R. E. W. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8848 · Cited by 83
Self-citationα-Helical Propensities of Amino Acids in the Hydrophobic Face of an Amphipathic α- Helix
Zhou, N., Monera, O. D., Kay, C. M., & Hodges, R. S. (1994) · Protein and Peptide Letters · doi:10.2174/0929866501666220424135225 · Cited by 81
Self-citationJacqueline, C. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.03.013 · Cited by 42
Temperature profiling of polypeptides in reversed-phase liquid chromatography
Mant, C. T., Tripet, B., & Hodges, R. S. (2003) · Journal of Chromatography A · doi:10.1016/s0021-9673(03)00919-1 · Cited by 39
Self-citationNew drugs for Gram-positive uropathogens
Wagenlehner, F., & Naber, K. G. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.02.002 · Cited by 36
Infective endocarditis: a review of the best treatment options
Calza, L., Manfredi, R., & Chiodo, F. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.9.1899 · Cited by 9
Cited by
Antibacterial peptides for therapeutic use: obstacles and realistic outlook
MARR, A., GOODERHAM, W., & HANCOCK, R. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.04.006 · Cited by 1,051
Self-citationPeptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides
Chongsiriwatana, N. P., Patch, J. A., Czyzewski, A. M., Dohm, M. T., Ivankin, A., Gidalevitz, D., Zuckermann, R. N., & Barron, A. E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708254105 · Cited by 657
Antimicrobial peptides: Structure, mechanism, and modification
Chen, N., & Jiang, C. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115377 · Cited by 279
Lima, P. G., Oliveira, J. T. A., Amaral, J. L., Freitas, C. D. T., & Souza, P. F. N. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119647 · Cited by 170
Metadata
- Authors
- Chen, Y., Mant, C. T., Farmer, S. W., Hancock, R. E. W., Vasil, M. L., & Hodges, R. S.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-04
- Volume
- 280
- Issue
- 13
- Pages
- 12316-12329
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2087125825
- Cited by
- 600
- References
- 43
- FWCI
- 12.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.